Working… Menu
Trial record 4 of 14 for:    abrocitinib | Atopic Dermatitis

Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis (JADE MOA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03915496
Recruitment Status : Recruiting
First Posted : April 16, 2019
Last Update Posted : March 24, 2021
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 6, 2021
Estimated Study Completion Date : October 4, 2021